ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 55 filers reported holding ENTELLUS MED INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,495,000 | +11.5% | 297,677 | 0.0% | 0.01% | +9.1% |
| Q2 2017 | $4,930,000 | +46.4% | 297,677 | +22.0% | 0.01% | +57.1% |
| Q1 2017 | $3,367,000 | +62.9% | 243,977 | +123.9% | 0.01% | +40.0% |
| Q4 2016 | $2,067,000 | +48.1% | 108,977 | +73.0% | 0.01% | +66.7% |
| Q3 2016 | $1,396,000 | -38.5% | 62,977 | -28.2% | 0.00% | 0.0% |
| Q2 2015 | $2,269,000 | +18.1% | 87,700 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,921,000 | – | 87,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $54,577,000 | 41.39% |
| Discovery Group I, LLC | 2,089,974 | $38,581,000 | 14.72% |
| Essex Woodlands Management, Inc. | 3,231,656 | $59,656,000 | 10.58% |
| Archon Capital Management LLC | 550,224 | $10,157,000 | 5.46% |
| First Light Asset Management, LLC | 632,737 | $11,680,000 | 3.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $6,303,000 | 2.45% |
| Ghost Tree Capital, LLC | 561,510 | $10,365,000 | 2.20% |
| Aisling Capital LLC | 528,655 | $9,759,000 | 1.60% |
| Cypress Capital Management LLC (WY) | 66,965 | $1,236,000 | 1.46% |
| Endurant Capital Management LP | 208,771 | $3,854,000 | 1.17% |